SIR Reporting Standards for the Treatment of Acute Limb Ischemia with Use of Transluminal Removal of Arterial Thrombus

Journal of Vascular and Interventional Radiology

Volumn 14, Issue 9 PART 2, 2003, Pages

  Patel, Nilesh ^a   Sacks, David ^a   Patel, Rajesh I ^a   Moresco, Kenneth P ^a   Ouriel, Kenneth ^a   Gray, Richard ^a   Ambrosius, Walter T ^a   Lewis, Curtis A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18444362051     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000094619.61428.11     Document Type: Article

References (72)

1. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. J Vasc Surg 31 suppl (2000) S1-S296
2. Working Party on Thrombolysis in the Management of Limb Ischemia. Thrombolysis in the management of lower limb peripheral arterial occlusion-a consensus document. Am J Cardiol 81 (1998) 207-218
3. McNamara T.O., and Fischer J.R. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. AJR Am J Roentgenol 144 (1985) 769-775
4. Beyersdorf F., Matheis G., Kruger S., et al. Avoiding reperfusion injury after limb revascularization: experimental observations and recommendations for clinical application. J Vasc Surg 9 (1989) 757-766
5. Sacks D., Marinelli D.L., Martin L.G., and Spies J.B. General principles for evaluation of new interventional technologies and devices. Technology Assessment Committee. J Vasc Interv Radiol 8 (1997) 133-136
6. Sacks D., Marinelli D.L., Martin L.G., and Spies J.B. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. Technology Assessment Committee J Vasc Interv Radiol 8 (1997) 137-149
7. Rutherford, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
8. Bettmann M.A. The present and the future for catheter-directed thrombolytic therapy. J Vasc Interv Radiol 6 suppl (1995) 1S-2S
9. Diffin D.C., and Kandarpa K. Assessment of peripheral intraarterial thrombolysis versus surgical revascularization in acute lower-limb ischemia: a review of limb salvage and mortality statistics. J Vasc Interv Radiol 7 (1996) 57-63
10. Katzen B.T., and Van Breda A. Low dose streptokinase in the treatment of arterial occlusions. AJR Am J Roentgenol 136 (1981) 1171-1178
11. Hess H., Ingrisch H., Mietaschk A., and Rath H. Local low-dose thrombolytic therapy of peripheral arterial occlusions. N Engl J Med 307 (1982) 1627-1630
12. Sullivan K.L., Gardiner Jr. G.A., Shapiro M.J., Bonn J., and Levin D.C. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Radiology 173 (1989) 805-808
13. Valji K., Roberts A.C., Davis G.B., and Bookstein J.J. Pulsed-spray thrombolysis of arterial and bypass graft occlusions. AJR Am J Roentgenol 156 (1991) 617-621
14. LeBlang S.D., Becker G.J., Benenati J.F., Zemel G., Katzen B.T., and Sallee S.S. Lowdose urokinase regimen for the treatment of lower extremity arterial and graft occlusions: experience in 132 cases. J Vasc Interv Radiol 3 (1992) 475-483
15. Sullivan K.L., Gardiner Jr. G.A., Kandarpa K., et al. Efficacy of thrombolysis in infrainguinal bypass grafts. Circulation 83 suppl (1991) 99-105
16. Durham J.D., and Rutherford R.B. Assessment of long-term efficacy of fibrinolytic therapy in the ischemic limb. Semin Intervent Radiol 9 (1992) 166-173
17. Ward A.S., Andaz S.K., and Bygrave S. Peripheral thrombolysis with tissue plasminogen activator: results of two treatment regimens. Arch Surg 129 (1994) 861-865
18. Decrinis M., Pilger E., Stark G., Lafer M., Obernosterer A., and Lammer J. A simplified procedure for intra-arterial thrombolysis with tissue-type plasminogen activator in peripheral arterial occlusive disease: primary and long-term results. Eur Heart J 14 (1993) 297-305
19. Berridge D.C., Gregson R.H., Hopkinson B.R., and Makin G.S. Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis. Br J Surg 78 (1991) 988-995
20. Meyerovitz M.F., Goldhaber S.Z., Reagan K., et al. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology 175 (1990) 75-78
21. Nilsson L., Albrechtsson U., Jonung T., et al. Surgical treatment versus thrombolysis in acute arterial occlusion: a randomised controlled study. Eur J Vasc Surg 6 (1992) 189-193
22. Graor R.A., Comerota A.J., Douville Y., et al. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 220 (1994) 251-266
23. Weaver F.A., Comerota A.J., Youngblood M., Froehlich J., Hosking J.D., and Papanicolaou G. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. J Vasc Surg 24 (1996) 513-521
24. Comerota A.J., Weaver F.A., Hosking J.D., et al. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am J Surg 172 (1996) 105-112
25. Ouriel K., Shortell C.K., DeWeese J.A., et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 19 (1994) 1021-1030
26. Ouriel K., Veith F.J., and Sasahara A.A. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J Vasc Surg 23 (1996) 64-73
27. Ouriel K., Veith F.J., and Sasahara A.A. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 338 (1998) 1105-1111
28. Kandarpa K. Technical determinants of success in catheter-directed thrombolysis for peripheral arterial occlusions. J Vasc Interv Radiol 6 suppl (1995) 55S-61S
29. Shortell C.K., and Ouriel K. Thrombolysis in acute peripheral arterial occlusion: predictors of immediate success. Ann Vasc Surg 8 (1994) 59-65
30. McNamara T.O., Gardner K.R., Bomberger R.A., and Greaser L.E. Clinical and angiographic selection factors for thrombolysis as initial therapy for acute lower limb ischemia. J Vasc Interv Radiol 6 suppl (1995) 36S-47S
31. Ouriel K., and Veith F.J. Acute lower limb ischemia: determinants of outcome. Surgery 124 (1998) 336-341
32. Reekers J.A., Kromhout J.G., Spithoven H.G., et al. Arterial thrombosis below the inguinal ligament: percutaneous treatment with a thrombosuction catheter. Radiology 198 (1996) 49-53
33. Wagner H.J., Muller-Hulsbeck S., Pitton M.B., Weiss W., and Wess M. Rapid thrombectomy with a hydrodynamic catheter: results from a prospective, multicenter trial. Radiology 205 (1997) 675-681
34. Gorich J., Rilinger N., Sokiranski R., et al. Mechanical thrombolysis of acute occlusion of both the superficial and the deep femoral arteries using a thrombectomy device. AJR Am J Roentgenol 170 (1998) 1177-1180
35. Henry M., Amor M., Henry I., Tricoche O., and Allaoui M. The Hydrolyser thrombectomy catheter: a single-center experience. J Endovascular Surgery 5 (1998) 24-31
36. Tadavarthy S.M., Murray P.D., Inampudi S., Nazarian G.K., and Amplatz K. Mechanical thrombectomy with the Amplatz device: human experience. J Vasc Interv Radiol 5 (1994) 715-724
37. Rousseau H., Sapoval M., Ballini P., et al. Percutaneous recanalization of acutely thrombosed vessels by hydrodynamic thrombectomy (Hydrolyser). Eur Radiol 7 (1997) 935-941
38. Rilinger N., Gorich J., Scharrer-Pamler R., et al. Short-term results with use of the Amplatz device in the treatment of acute lower limb occlusions. J Vasc Interv Radiol 8 (1997) 343-348
39. Huettl E.A., and Soulen M.C. Thrombolysis of lower extremity embolic occlusions: a study of the results of the STAR Registry. Radiology 197 (1995) 141-145
40. Blaisdell F.W., Steele M., and Allen R.E. Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surgery 84 (1978) 822-834
41. Jivegard L., Holm J., and Schersten T. Arterial thromboembolectomy-should anticoagulants be administered?. Acta Chir Scand 152 (1986) 493-497
42. Wholey M.H., Maynar M.A., Wholey M.H., et al. Comparison of thrombolytic therapy of lower-extremity acute, subacute, and chronic arterial occlusions. Cathet Cardiovasc Diagn 44 (1998) 159-169
43. Ikeda Y., Rummel M.C., Field C.K., et al. Relationship of runoff vessels to results following thrombolysis and revascularization for synthetic graft occlusions. Am Surg 61 (1995) 481-485
44. Starck E.E., McDermott J.C., Crummy A.B., Turnipseed W.D., Acher C.W., and Burgess J.H. Percutaneous aspiration thromboembolectomy. Radiology 156 (1985) 61-66
45. Sharafuddin M.J., and Hicks M.E. Current status of percutaneous mechanical thrombectomy. I. General principles. J Vasc Interv Radiol 8 (1997) 911-921
46. Sharafuddin M.J., and Hicks M.E. Current status of percutaneous mechanical thrombectomy. II. Devices and mechanisms of action. J Vasc Interv Radiol 9 (1998) 15-31
47. Sharafuddin M.J., and Hicks M.E. Current status of percutaneous mechanical thrombectomy. III. Present and future applications. J Vasc Interv Radiol 9 (1998) 209-224
48. McNamara T.O., and Bomberger R.A. Factors affecting initial and 6 month patency rates after intraarterial thrombolysis with high dose urokinase. Am J Surg 152 (1986) 709-712
49. Gardiner Jr. G.A., Harrington D.P., Koltun W., Whittemore A., Mannick J.A., and Levin D.C. Salvage of occluded arterial bypass grafts by means of thrombolysis. J Vasc Surg 9 (1989) 426-431
50. Ouriel K., Kandarpa K., Schuerr D.M., Hultquist M., Hodkinson G., and Wallin B. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial. J Vasc Interv Radiol 10 (1999) 1083-1091
51. Elliott Jr. J.P., Hageman J.H., Szilagyi E., Ramakrishnan V., Bravo J.J., and Smith R.F. Arterial embolization: problems of source, multiplicity, recurrence, and delayed treatment. Surgery 88 (1980) 833-845
52. Jivegard L., Holm J., and Schersten T. The outcome in arterial thrombosis misdiagnosed as arterial embolism. Acta Chir Scand 152 (1986) 251-256
53. Sicard G.A., Schier J.J., Totty W.G., et al. Thrombolytic therapy for acute arterial occlusion. J Vasc Surg 2 (1985) 65-78
54. Kaul A.F. Pharmacoeconomic considerations in peripheral arterial thrombolytic therapy. J Vasc Interv Radiol 6 suppl (1995) 104S-110S
55. Patel S.T., Haser P.B., Bush Jr. H.L., and Kent K.C. Is thrombolysis of lower extremity acute arterial occlusion cost-effective?. J Surg Res 83 (1999) 106-112
56. Van Breda A., Graor R.A., Katzen B.T., Risius B., and Gillings D. Relative cost-effectiveness of urokinase versus streptokinase in the treatment of peripheral vascular disease. J Vasc Interv Radiol 2 (1991) 77-87
57. Janosik J.E., Bettmann M.A., Kaul A.F., and Souney P.F. Therapeutic alternatives for subacute peripheral arterial occlusion. Comparison by outcome, length of stay, and hospital charges. Invest Radiol 26 (1991) 921-925
58. Ouriel K., Kolassa M., DeWeese J.A., and Green R.M. Economic implications of thrombolysis or operation as the initial treatment modality in acute peripheral arterial occlusion. Surgery 118 (1995) 810-814
59. Mark D.B., Hlatky M.A., Califf R.M., et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 332 (1995) 1418-1424
60. Weber J.J., and Chong K. Regional thrombolytic infusion for peripheral arterial occlusion: is urokinase really the drug of choice?. Am J Health Syst Pharm 55 (1998) 2414-2416
61. White H.D. Selecting a thrombolytic agent. Cardiol Clin 13 (1995) 347-354
62. Perler B.A. Cost-efficacy issues in the treatment of peripheral vascular disease: primary amputation or revascularization for limb-threatening ischemia. J Vasc Interv Radiol 6 suppl (1995) 111S-115S
63. Schwartz J.S. Clinical economics and noncoronary vascular disease. J Vasc Interv Radiol 6 suppl (1995) 116S-124S
64. Mark D.B. Clinical and economic lessons from studies of coronary thrombolysis. J Vasc Interv Radiol 6 suppl (1995) 94S-101S
65. Hunink M.G., Wong J.B., Donaldson M.C., Meyerovitz M.F., de Vries J., Harrington D.P., et al. Revascularization for femoropopliteal disease: a decision and cost-effectiveness analysis. JAMA 274 (1995) 165-171
66. Yin D., Forman H.P., and Langlotz C.P. Evaluating health services: the importance of patients' preferences and quality of life. AJR Am J Roentgenol 165 (1995) 1323-1328
67. Yin D., and Forman H.P. Health care costbenefit and cost-effectiveness analysis: an overview. J Vasc Interv Radiol 6 (1995) 311-320
68. Dawson-Saunders B., and Trapp R.G. Basic and clinical biostatistics (1994), Appleton & Lange, Norwalk CT
69. Begg C., Cho M., Eastwood S., et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 276 (1996) 637-639
70. Collet D. Modelling survival data in medical research (1994), Chapman & Hall, London
71. Wiles A., Atkinson G., Huson L., et al. Good statistical practice in clinical research: guideline standard operating procedures. Drug Information J 28 (1994) 615-627
72. Little R., and Rubin R.B. Statistical analysis with missing data (1987), John Wiley & Sons, New York